?? Happy Thanksgiving from Landmark Bio! As we reflect on the year, we're filled with gratitude for the incredible team members, partners, and clients who make our journey so rewarding. Wishing you all a safe and restful Thanksgiving with your loved ones. #Thanksgiving #Gratitude?
关于我们
Landmark Bio is a collective endeavor launched by leaders from academia, the life sciences industry, and world-renowned research hospitals to accelerate development and industrialization of next-generation genomic medicine. Inspired by recent advancements in cell and gene therapy, Landmark Bio was established to remove barriers in drug development, create accessible capability, expertise, and solutions, and offer a collaboration platform to advance manufacturing technologies for the new generation of medicines to come. Founding partners include Harvard University, Massachusetts Institute of Technology (MIT), Cytiva, FUJIFILM Diosynth Biotechnologies (FDB), and Alexandria Real Estate Equities, Inc. Other collaborating institutions include Beth Israel Deaconess Medical Center, Boston Children’s Hospital, Mass General Brigham, and the Dana-Farber Cancer Institute. For more information please contact [email protected]
- 网站
-
https://www.landmarkbio.com
Landmark Bio的外部链接
- 所属行业
- 生物技术研究
- 规模
- 51-200 人
- 总部
- Watertown，Massachusetts
- 类型
- 私人持股
地点
-
主要
获取路线
300 N Beacon St
US，Massachusetts，Watertown，02472
Landmark Bio员工
-
Ran Zheng
CEO at Landmark Bio
-
Olga Mollin
Purposeful Biopharma Senior Leader | Trusted Operations & Program Expertise | Strong Commitment to Customer Partnership
-
Eli Kraus
Associate Vice President of Process and Analytical Development at Landmark Bio
-
Michael Covington
Chief Quality and Regulatory Officer at Landmark Bio
动态
-
Landmark Bio转发了
In today’s fast-paced biotech world, seamless data flow and integration are essential for successful product development. However, many organizations struggle with siloed data, complex systems, and knowledge transfer across teams and external partners. ? In her latest article, Shanti Chari of Digital Technologies and Innovation at Landmark Bio, explores the key barriers to data integration and tech transfer in biotech. She offers solutions like unified digital platforms, standardized data models, and seamless integrations to create continuous digital threads that accelerate decision-making and drive value. #biotech #dataintegration #digitaltransformation #biomanufacturing #cellandgene To read the full article, please visit our News & Publications page on our website: https://lnkd.in/end5g9Tw
-
In today’s fast-paced biotech world, seamless data flow and integration are essential for successful product development. However, many organizations struggle with siloed data, complex systems, and knowledge transfer across teams and external partners. ? In her latest article, Shanti Chari of Digital Technologies and Innovation at Landmark Bio, explores the key barriers to data integration and tech transfer in biotech. She offers solutions like unified digital platforms, standardized data models, and seamless integrations to create continuous digital threads that accelerate decision-making and drive value. #biotech #dataintegration #digitaltransformation #biomanufacturing #cellandgene To read the full article, please visit our News & Publications page on our website: https://lnkd.in/end5g9Tw
Getting Tech Transfer Right First Time
https://landmarkbio.com
-
Today, and every day, we honor the brave men and women who have served our country. ? Your sacrifices, courage, and commitment are deeply appreciated. #VeteransDay #ThankYouForYourService #Gratitude
-
-
?? Happy Halloween from Landmark Bio! ?? We had a fantastic time celebrating at our company Halloween party! A huge shoutout to everyone who joined in and embraced the spooky spirit with amazing costumes and creativity! #Halloween2024 #CompanyCulture
-
-
This week, Robert DeLong, Director of RNA and Formulation Development at Landmark Bio shared his biotechnology journey with the University of New Hampshire biotech class, discussing his experiences in academia, running his own lab, and his current role at Landmark Bio. As an expert in the mRNA field, Rob provided invaluable insights into the industry and the evolving landscape of biotechnology. The students were engaged and eager to learn from his expertise! ?? ? A big thank you to Rob for inspiring the next generation of biotech professionals and UNH for having him as a guest speaker! #Biotechnology #CareerDevelopment #ThoughtLeadership
-
-
?? Congratulations to our CEO, Ran Zheng, on her election to the 2025 Alliance for Regenerative Medicine Board of Directors! Also, a big shoutout to the entire ARM team for a successful Meeting on the Mesa this week! #Leadership #ARM #CGMesa24
ARM has kicked off #CGMesa24 with a big announcement! At the conference’s opening, we officially elected our 2025 Board of Directors. These distinguished individuals will be key to ARM’s leadership of the sector. A big welcome to our new board members: Matthew Durdy, MA, MBA, Chief Executive, Cell and Gene Therapy Catapult George Eastwood, Board Chair & Executive Director, Emily Whitehead Foundation Anne-Virginie Eggimann, Chief Regulatory Officer, Tessera Therapeutics Sadik Kassim, Chief Technical Officer & Chief Scientific Officer, Danaher Genomic Medicines Christy Siegel, Senior Vice President & US Therapeutic Area Head, Immunology, Novartis Manny Simons, Chief Executive Officer & Co-Founder, Akouos; Senior Vice President, Gene Therapy, Eli Lilly and Company Fyodor Urnov, Director, Technology & Translation, Innovative Genomics Institute Ran Zheng, Chief Executive Officer, Landmark Bio Read the full release:?https://lnkd.in/edqJpcbh
-
-
We are excited to be at the Cell and Gene Meeting on the Mesa, hosted by the Alliance for Regenerative Medicine! Ran Zheng, Todd Howren, Ph.D., and Kris Ward are eager to dive into meaningful discussions, connect with industry leaders, and explore the latest advancements in #cellandgenetherapy. Reach out in the partner portal today—we’d love to connect! #CGMesa24
-
-
We are counting down the days to the 2024 Cell & Gene Meeting on the Mesa with Alliance for Regenerative Medicine! Ran Zheng, Todd Howren, Ph.D. and Kris Ward are excited to collaborate with industry leaders, exchange innovative ideas, and help shape the future of healthcare. Don’t miss out—connect with us in the partner portal today! #CGMesa24
-
-
?? We are reflecting on an amazing experience at the World Medical Innovation Forum! ?? Several members of our team had the opportunity to engage with inspiring leaders, innovative thinkers, and passionate professionals in the healthcare sector this week at the World Medical Innovation Forum in Boston. A huge thank you to Mass General Brigham for hosting such a valuable event. Here’s to driving innovation and collaboration in our industry! #WorldMedicalInnovationForum #ThankYou #HealthcareInnovation #Networking #Biotech
-